Abstract | AIM: METHODS: RESULTS: hTERT mRNA was detected in 28 of 33 (84.85%) of serum obtained from cholangiocarcinoma patients and 9 of 41 (21.9%) of serum obtained from benign biliary tract disease patients. hTERT mRNA was not detected in any serum obtained from healthy volunteers. on the other hand the common tumor marker, CA19-9 was detected in 20 of 33 (60.6%) of serum obtained from cholangiocarcinoma patients and 8 of 41 (19.5%) of serum obtained from benign biliary tract disease patients. However, no correlation was found between the present of serum hTERT mRNA and tumor staging. CONCLUSION:
|
Authors | Kawin Leelawat, Surang Leelawat, Thawee Ratanachu-Ek, Somboon Trubwongchareon, Jerasak Wannaprasert, Saad Tripongkaruna, Suchart Chantawibul, Panadda Tepaksorn |
Journal | World journal of gastroenterology
(World J Gastroenterol)
Vol. 12
Issue 26
Pg. 4195-8
(Jul 14 2006)
ISSN: 1007-9327 [Print] United States |
PMID | 16830373
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Biomarkers, Tumor
- DNA-Binding Proteins
- RNA, Messenger
- Telomerase
|
Topics |
- Adult
- Aged
- Aged, 80 and over
- Bile Duct Neoplasms
(blood, diagnosis, pathology)
- Bile Ducts, Intrahepatic
- Biomarkers, Tumor
(blood)
- Cell Line, Tumor
- Cholangiocarcinoma
(blood, diagnosis, pathology)
- DNA-Binding Proteins
(genetics, metabolism)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Male
- Middle Aged
- Neoplasm Staging
- RNA, Messenger
(blood)
- Reverse Transcriptase Polymerase Chain Reaction
- Telomerase
(genetics, metabolism)
|